Pharma

Your Article Summary

See Latest Articles

Pharmaceutical Antitrust
Corporate News Releases - The Healthcare Sales & Marketing Network, 11/17/08

The DG-Comp's Sector Inquiry has brought the importance of managing antitrust issues at every stage of a pharmaceutical product's lifecycle into renewed focus. It is vital for innovators, generics and their counsel to understand how to employ legal, regulatory and commercial strategies without running foul of competition rules. The Inquiry has been examining many potential barriers to the introduction of generic drugs to the market in order to determine existing or potential antitrust violations.

Today in Regulatory Issues...keeping you current

Receive free subspecialty "5-minute updates" via email

Sixteen Fired for Records Snooping
HealthDataManagement, 12/09/09

Watson Files FDA Application for Generic Rozerem
Watson Pharmaceuticals, 12/07/09

Bristol-Myers Squibb And Pfizer Announce Plans To Submit Regulatory Filing For Apixaban In Europe
Bristol Myers-Squibb Company, 12/07/09

 See all of Regulatory Issues